Metabolic syndrome in HIV-positive patients

被引:8
|
作者
Drelichowska, Justyna [1 ,2 ]
Kwiatkowska, Wieslawa [1 ,2 ]
Knysz, Brygida [3 ]
Witkiewicz, Wojciech [1 ]
机构
[1] Reg Specialist Hosp Wroclaw, Wrovasc Integrated Cardiovas Ctr, Res Dev Ctr, Wroclaw, Poland
[2] Reg Specialist Hosp Wroclaw, Res Dev Ctr, Dept Angiol, Wroclaw, Poland
[3] Wroclaw Med Univ, Liver Diseasesand Acquired Immune Deficiencies, Dept Infect Dis, Wroclaw, Poland
来源
HIV & AIDS REVIEW | 2015年 / 14卷 / 02期
关键词
HIV; Antiretroviral therapy; Metabolic syndrome; Lipodystrophy; Hypertriglyceridemia; Cholesterol;
D O I
10.1016/j.hivar.2014.09.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A number of abnormalities related to chronic infection and antiretroviral treatment may be observed in a population of HIV-positive patients. A particular state of coexisting, interacting and interrelated disorders referred to as metabolic syndrome is observed in 7-45% of patients infected with HIV. Its presence is related to the abnormalities of adipose tissue distribution known under a common name of ART-related lipodystrophy syndrome. The most common features of metabolic syndrome observed in a course of HIV infection include hypertriglyceridemia and low HDL cholesterol concentration, while increased waist circumference is the least frequently observed. Treatment of metabolic syndrome encompasses revision and possible changes in antiretroviral therapy, diet, changes in physical activity, pharmacological management of individual components of the syndrome. In this publication we present a review of problems concerning epidemiology, pathophysiology, symptoms and treatment of metabolic syndrome in HIV-positive patients. (C) 2014 Polish AIDS Research Society. Published by Elsevier Sp.zo.o.All rights reserved.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 50 条
  • [31] Insomnia in older HIV-positive patients
    Salles, Cristina
    Cruz, Miguel Meira e
    Freire, Igor Cardoso
    Gonzaga, Lucas Haine
    Dias, Cristiane Costa
    SLEEP SCIENCE, 2022, 15 (03) : 363 - 369
  • [32] Determinants of survival in HIV-positive patients
    Baillargeon, J
    Borucki, M
    Black, SA
    Dunn, K
    INTERNATIONAL JOURNAL OF STD & AIDS, 1999, 10 (01) : 22 - 27
  • [33] Cardiovascular disease in HIV-positive patients
    Kamin, DS
    Grinspoon, SK
    AIDS, 2005, 19 (07) : 641 - 652
  • [34] Evaluation of HIV-Related Cardiomyopathy in HIV-Positive Patients in Bushehr, Iran
    Abbasi, Farhad
    Alexander, Asha
    Fardkhani, Soolmaz Korooni
    Iranpour, Dariush
    Mirzaei, Kamran
    Kalantarhormozi, Mohammadreza
    Haghighi, Mehrdad
    Bagheri, Marziyeh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [35] The metabolic syndrome in HIV
    Worm, Signe W.
    Lundgren, Jens D.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 25 (03) : 479 - 486
  • [36] Echocardiographic screening for pulmonary arterial hypertension in HIV-positive patients
    ten Freyhaus, H.
    Vogel, D.
    Lehmann, C.
    Kuemmerle, T.
    Wyen, C.
    Faetkenheuer, G.
    Rosenkranz, S.
    INFECTION, 2014, 42 (04) : 737 - 741
  • [37] Metabolic Syndrome in Children and Adolescents Living with HIV
    Espiau, Maria
    Yeste, Diego
    Noguera-Julian, Antoni
    Gonzalez-Tome, Maria I.
    Falcon-Neyra, Lola
    Gavilan, Cesar
    Navarro-Gomez, Maria L.
    Mellado-Pena, Maria J.
    Gracia-Casanova, Mercedes
    Colino-Gil, Maria E.
    Mendez, Maria
    Ciria Calavia, Luis M.
    Fortuny, Claudia
    Carrascosa, Antonio
    Soler-Palacin, Pere
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (06) : E171 - E176
  • [38] Attitudes and barriers to employment in HIV-positive patients
    Rodger, A. J.
    Brecker, N.
    Bhagani, S.
    Fernandez, T.
    Johnson, M.
    Tookman, A.
    Bartley, A.
    OCCUPATIONAL MEDICINE-OXFORD, 2010, 60 (06): : 423 - 429
  • [39] Vascular access outcomes in HIV-positive patients
    Mistry, Hiren
    Lifford, Rhiannon
    Stephenson, Matthew A.
    Valenti, Domenico
    JOURNAL OF VASCULAR ACCESS, 2012, 13 (04) : 459 - 463
  • [40] Treatment options for lipodystrophy in HIV-positive patients
    Behrens, Georg Mn
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (01) : 39 - 52